Huini Wu

Affiliations: 
2014-2017 University of Illinois at Chicago, Chicago, IL, United States 
Google:
"Huini Wu"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Huang Y, Yang L, Lin Y, et al. (2019) Prognostic value of non-invasive serum Cytokeratin 18 detection in gastrointestinal cancer: a meta-analysis. Journal of Cancer. 10: 4814-4823
Lin Y, Liu Z, Qiu Y, et al. (2018) Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Yuan CL, He F, Ye JZ, et al. (2017) APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis. Oncotarget. 8: 59720-59728
Xu L, He F, Wang H, et al. (2017) A high plasma D-dimer level predicts poor prognosis in gynecological tumors in East Asia area: a systematic review and meta-analysis. Oncotarget. 8: 51551-51558
Feng Y, He F, Yan S, et al. (2017) The Role of GOLPH3L in the Prognosis and NACT response in Cervical Cancer. Journal of Cancer. 8: 443-454
Xu L, Wu H, Jiang C, et al. (2016) Dacomitinib, a new pan-EGFR inhibitor, is effective in killing ovarian cancer cells. Discovery Medicine. 22: 297-309
Wang D, Lin Y, Gao B, et al. (2016) Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer. Journal of Cancer. 7: 1226-32
Yan S, He F, Gao B, et al. (2016) Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study. Journal of Cancer. 7: 618-25
Yan S, He F, Luo R, et al. (2015) Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine
Feng Y, He F, Wu H, et al. (2015) GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer. Journal of Cancer. 6: 893-900
See more...